Ballentine Partners’s American Healthcare REIT AHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$550K Buy
10,543
+144
+1% +$7.08K 0.01% 539
2026
Q1
$490K Sell
10,399
-123
-1% -$6.1K 0.01% 539
2025
Q4
$495K Sell
10,522
-273
-3% -$12.7K 0.01% 508
2025
Q3
$453K Buy
10,795
+50
+0.5% +$2.01K 0.01% 541
2025
Q2
$395K Buy
10,745
+1,091
+11% +$36.3K 0.01% 570
2025
Q1
$293K Buy
+9,654
New +$278K 0.01% 638

Other funds holding AHR

Ballentine Partners's AHR Position: Q2 2026 in Review

Ballentine Partners increased its American Healthcare REIT (AHR) stake by 1.4% in Q2 2026, buying an estimated $7.08K and bringing the position to 10,543 shares worth $550K. The position accounts for 0.01% of the portfolio, ranked #539.

Ballentine Partners first reported a position in AHR in Q1 2025 and has held it in 6 quarters since. 571 funds tracked by Wall St. Rank hold AHR as of Q2 2026.

  • Ballentine Partners held 10,543 shares of American Healthcare REIT worth $550K as of Q2 2026.
  • Ballentine Partners bought 144 American Healthcare REIT shares in Q2 2026, an estimated $7.08K.
  • American Healthcare REIT made up 0.01% of Ballentine Partners's portfolio in Q2 2026, its #539 holding.
  • Ballentine Partners first reported a position in American Healthcare REIT in Q1 2025 and has held it in 6 quarters since.
  • 571 funds tracked by Wall St. Rank held American Healthcare REIT as of Q2 2026.

Based on Ballentine Partners's 13F filing for Q2 2026, filed 17 Jul 2026.